No connection

Search Results

HCXY

BEARISH
$24.76 Live
Hercules Capital, Inc. · NYSE
$24.36 52W Range $25.71
Overview AI Snowflake Price Valuation Profitability Growth Health SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 28, 2026
Market cap
$1.31B
P/E
19.22
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
75%
The deterministic health profile for HCXY is critical, headlined by a Piotroski F-Score of 1/9, indicating severe deterioration in financial strength and operational efficiency. While the stock has shown long-term price appreciation over five years, current technical trends are completely bearish (0/100) and dividend strength is non-existent in the provided data. Valuation is stretched with a Price-to-Book ratio of 2.41, which is significantly high for a Business Development Company (BDC) structure. The combination of poor financial health scores and stagnant recent price action suggests significant downside risk.

Key Strengths

Positive 5-year price change of 26.3%
Positive 3-year price change of 20.8%
Low 52-week volatility (tight trading range)
Market capitalization of $1.31B provides some scale
Consistent SEC filing history

Key Risks

Critical financial health failure (Piotroski F-Score 1/9)
Overvaluation relative to book value (P/B 2.41)
Bearish technical trend (0/100)
Zero dividend strength score despite BDC structure
Weak insider sentiment (40/100)
AI Fair Value Estimate
Based on comprehensive analysis
$15.4
-37.8% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
24
Weak
Value
30
Future
20
Past
60
Health
11
Dividend
0
AI Verdict
High Risk / Avoid
Key drivers: Piotroski F-Score of 1/9, Bearish technicals, High P/B ratio
Confidence
80%
Value
30/100

Ref P/E 19.22, P/B 2.41

Positives
No standout positives identified.
Watchpoints
  • P/B of 2.41 is expensive for the industry
  • P/E of 19.22 lacks growth support
Future
20/100

Ref Technical Trend and Growth Metrics

Positives
No standout positives identified.
Watchpoints
  • Technical trend is 0/100
  • No evidence of revenue or earnings growth
Past
60/100

Ref Historical Price Performance

Positives
  • Positive 5Y and 3Y returns
Watchpoints
  • Recent 6-month growth is nearly flat (+0.6%)
Health
11/100

Ref Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score 1/9 indicates extreme weakness
Dividend
0/100

Ref Dividend Strength

Positives
No standout positives identified.
Watchpoints
  • Dividend strength score is 0/100

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$24.76

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for HCXY and closest competitors.

Updated 2026-04-27
HCX
Hercules Capital, Inc.
Primary
5Y
+26.3%
3Y
+20.8%
1Y
+6.4%
6M
+0.6%
1M
+0.6%
1W
-0.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
19.22
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
2.41
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$1.31B

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

SEC Filings

Recent regulatory filings from the SEC EDGAR database

DEF 14A
DEF 14A
2026-04-23

HCXY filed a definitive proxy statement on April 23, 2026, providing shareholders with necessary information to vote on corporate matters at the upcoming annual meeting.

8-K
8-K
2026-02-12

HCXY likely filed this 8-K to announce its fourth quarter and full-year financial results.

10-K
10-K
2026-02-12

HCXY filed its annual 10-K report on February 12, 2026. The provided excerpts do not contain specific financial metrics or detailed risk disclosures, though they reference the existence of Business, Risk Factors, and MD&A sections.

8-K
8-K
2026-02-10

HCXY filed an 8-K on February 10, 2026, likely to announce its financial results for the fiscal year ended December 31, 2025.

8-K
8-K
2026-02-03

HCXY likely filed this 8-K to report its fourth-quarter and full-year financial results for the preceding fiscal year.

8-K
8-K
2025-10-30

HCXY filed an 8-K on October 30, 2025, likely to report its third-quarter financial results.

10-Q
10-Q
2025-10-30

HCXY filed its quarterly 10-Q report on October 30, 2025. While specific financial highlights were not provided in the excerpt, the company outlines its risk factors under Item 1A of the filing.

8-K
8-K
2025-07-31

HCXY filed an 8-K likely to report its second-quarter financial results for 2025.

10-Q
10-Q
2025-07-31

HCXY filed its quarterly 10-Q report on July 31, 2025. While specific financial highlights were not provided in the excerpt, the filing includes a dedicated section for risk factors under Item 1A.

8-K
8-K
2025-06-20
8-K
8-K
2025-06-16
8-K
8-K
2025-05-01
10-Q
10-Q
2025-05-01
DEF 14A
DEF 14A
2025-04-24
8-K
8-K
2025-03-10
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning HCXY from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile